Please assess the completion status of the following clinical trial:

Trial Title: Stereotaxis Computed Tomography (CT) Co-Registration Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be between 18-80 years of age~* Willing and able to provide prior written informed consent~* Patients present with a single bifurcated lesion or single non-CTO complex lesion requiring PCI.~* Able to be safely exposed to magnetic fields, such as magnetic resonance imaging (MRI)~* CT angiography performed prior to cardiac catheterization (must be performed \>48 hours prior to procedure to limit peri-procedural contrast use, but \<12 months prior to the procedure)~Exclusion Criteria:~* Patients with a creatinine greater than 2.0 mg/dL~* Exclude patients whom in the Investigator's opinion, are hemodynamically unstable on the day of the procedure.~* Untreatable allergy to contrast media~* Patients who have undergone CT angiography within 48 hours of index PCI procedure~* Patients with chronic total occlusions (CTOs) requiring intervention.~* Patients requiring treatment for lesions other than the single bifurcated or single non-CTO complex lesion.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Group A-CT Coregistration (Type: ACTIVE_COMPARATOR): 5 subjects with CT co-registration in a magnetically navigated PCI (Group A)
- Group B-Angiographic (Type: ACTIVE_COMPARATOR): 5 subjects with angiographic co-registration in a magnetically navigated PCI (Group B)
- Group C-Standard Angiography (Type: ACTIVE_COMPARATOR): 5 subjects with standard angiography in a conventional PCI (Group C)

Based on this trial design, predict the completion outcome and termination type (if applicable).